Department of Physiology, Justus Liebig University Giessen, Giessen, Germany.
Department of Internal Medicine I, Division of Cardiology, University Hospital Jena, Friedrich Schiller University, Am Klinikum 1, 07747, Jena, Germany.
Sci Rep. 2024 Aug 27;14(1):19885. doi: 10.1038/s41598-024-70382-x.
Patient age is critical for mesenchymal stem cell quality and differentiation capacity. We demonstrate that proliferation and adipogenic capacity of subcutaneous adipose stem cells (ASCs) from female patients declined with advanced age, associated with reduction in cell nucleus size, increase in nuclear lamina protein lamin B1/B2, and lamin A, upregulation of senescence marker p16INK4a and senescence-associated β-galactosidase activity. Adipogenic induction resulted in differentiation of adipocytes and upregulation of adipogenic genes CCAAT enhancer binding protein alpha, fatty acid binding protein 4, lipoprotein lipase, and peroxisome proliferator-activated receptor-γ, which was not affected by the Sirt-1 activator YK-3-237 or the Sirt-1 inhibitor EX-527. Protein expression of the stem cell markers Oct4 and Sox2 was not significantly downregulated with advanced patient age. Mitochondrial reactive oxygen species were increased in ASCs from old-aged patients, whereas protein expression of NADPH oxidases NOX1 and NOX4 was downregulated, and dual oxidase isoforms remained unchanged. Generation of nitric oxide and iNOS expression was downregulated. Protein expression of Sirt-1 and Sirt-3 decreased with patient age, whereas Sirt-2 and Sirt-5 remained unchanged. Induction of adipogenesis stimulated protein expression of Sirt-1 and Sirt-3, which was not affected upon pre-incubation with the Sirt-1-activator YK-3-237 or the Sirt-1-inhibitor EX-527. The Sirt-1 inhibitor Sirtinol downregulated adiponectin protein expression and the number of adipocytes, whereas YK-3-237 exerted stimulatory effects. In summary, our data demonstrate increased oxidative stress in ASCs of aging patients, and decline of adipogenic capacity due to Sirt-1- mediated adiponectin downregulation in elderly patients.
患者年龄对间充质干细胞的质量和分化能力至关重要。我们证明,来自女性患者的皮下脂肪干细胞(ASCs)的增殖和脂肪生成能力随着年龄的增长而下降,这与细胞核大小减小、核膜蛋白 lamin B1/B2 和 lamin A 增加、衰老标志物 p16INK4a 和衰老相关β-半乳糖苷酶活性上调有关。脂肪生成诱导导致脂肪细胞分化和脂肪生成基因 CCAAT 增强子结合蛋白α、脂肪酸结合蛋白 4、脂蛋白脂肪酶和过氧化物酶体增殖物激活受体-γ 的上调,这些基因不受 Sirt-1 激活剂 YK-3-237 或 Sirt-1 抑制剂 EX-527 的影响。随着患者年龄的增长,干细胞标志物 Oct4 和 Sox2 的蛋白表达没有明显下调。来自老年患者的 ASC 中活性氧增加,而 NADPH 氧化酶 NOX1 和 NOX4 的蛋白表达下调,双氧化酶同工型保持不变。一氧化氮和 iNOS 表达的产生下调。Sirt-1 和 Sirt-3 的蛋白表达随着患者年龄的增长而降低,而 Sirt-2 和 Sirt-5 保持不变。脂肪生成的诱导刺激 Sirt-1 和 Sirt-3 的蛋白表达,而用 Sirt-1 激活剂 YK-3-237 或 Sirt-1 抑制剂 EX-527 预孵育不会影响其表达。Sirt-1 抑制剂 Sirtinol 下调脂联素蛋白表达和脂肪细胞数量,而 YK-3-237 则发挥刺激作用。总之,我们的数据表明,衰老患者的 ASC 中氧化应激增加,并且由于 Sirt-1 介导的脂联素下调,老年患者的脂肪生成能力下降。